who compounds tirzepatide Compounding pharmacies can resume making as FDA reconsiders shortage Tirzepatide | C225H348N48O68 | CID

How investigative journalist Gary Taubes learned to spot bad science in nutrition, why that matters for your health decisions, and how to think more like a careful scientist yourself.

stomach paralysis is a rare side effect of using semaglutide, the active ingredient in the diabetes and weight loss drugs Ozempic, Wegovy, and Rybelsus, tens of thousands are at risk of developing it if we consider the millions of people taking these medications.

New research suggests GLP-1 medications may influence osteoarthritis beyond weight loss

We think you should count calories on a GLP-1, but to make sure youre eating enough, not to control them

Healio recently wrote about interesting new research shared by Tina Yi-Jin Hsieh, MD MPH, clinical researcher at Harvard Medical School showing that GLP-1 receptor agonists can reduce the risk of uterine fibroids in women with type 2 diabetes

Virtual chronic care company Omada, which went public less than a year ago, reported a quarterly profit for the first time.